Related Experiment Video
Updated: Aug 21, 2026

The 6-hydroxydopamine Rat Model of Parkinson's Disease
Published on: October 27, 2021
[Mechanism of specific dopaminergic neuronal death in Parkinson's disease]
Norio Ogawa1, Masato Asanuma, Ko Miyoshi
1Department of Brain Science, Okayama University Graduate School of Medicine and Dentistry.
Abstract:
Parkinson's disease (PD) is characterized by progressive degeneration of dopaminergic (DAergic) neurons of the nigrostriatal system, with resulting reduction in striatal dopamine (DA) concentration. Various mechanisms have been implicated in the pathogenesis and progression of PD. Among them, mitochondrial dysfunction, inflammation and oxidative stress had been accepted as the most plausible mechanism of disease progression. The free radicals/oxidative stress produced by MPTP, 6-hydroxydopamine, rotenone, activated microglias, and disturbances in mitochondrial respiratory enzymes provide a common pathway for the progression of all kinds of neurons. On the other hand, numerous studies on DA-induced neurotoxicity have been reported recently, and DA itself exerts cytotoxicity in DAergic neurons mainly due to the generation of highly reactive DA -quinones which are DAergic neuron-specific cytotoxic molecules. DA quinones may irreversibly alter protein function through the formation 5-cysteinyl-dopamine on the protein. For example, the formation of DA quinone-alpha-synuclein complex consequently increases cytotoxic protofibrils and covalent modification of functional enzymes. Thus, DA quinones play an important role in 'specific' DAergic neuro-degeneration of PD.
Related Concept Videos
Parkinson Disease ll: Pathophysiology
Parkinson's Disease: Overview
Parkinson Disease l: Introduction
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Neural Regulation
Alzheimer Disease ll: Pathophysiology
